
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Hilleman Laboratories
Deal Size : Undisclosed
Deal Type : Termination
Auro Vaccines Terminates License Agreement with Hilleman Laboratories Singapore
Details : Auro terminated the license agreement with Hilleman Labs to develop, manufacture and commercialize a pentavalent vaccine candidate used in children vaccination.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 06, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Hilleman Laboratories
Deal Size : Undisclosed
Deal Type : Termination

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hev-Sg-V
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : PATH | Coalition for Epidemic Preparedness Innovations | Cincinnati Children's Hospital Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Immunogenicity of a Nipah Virus Vaccine
Details : Hev-Sg-V is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Henipavirus Infections.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 13, 2019
Lead Product(s) : Hev-Sg-V
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : PATH | Coalition for Epidemic Preparedness Innovations | Cincinnati Children's Hospital Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ebola Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Accelovance | US Department of Defense
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Details : Ebola Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hemorrhagic Fever, Ebola.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
March 24, 2016
Lead Product(s) : Ebola Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Accelovance | US Department of Defense
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Rvsv
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Rvsv is a Virus-drug Conjugate drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of HIV Infections.
Product Name : Undisclosed
Product Type : Virus-drug Conjugate
Upfront Cash : Inapplicable
May 21, 2013
Lead Product(s) : Rvsv
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
